Chester County News and Community Website
YARDLEY, PA — Optinose (NASDAQ: OPTN) has released its financial results for the quarter ending June 30, 2024, along with key operational updates.
Optinose Reports Q2 2024 Financial Results and Operational Highlights Read More
CHESTERBROOK, PA — Trevena, Inc. (Nasdaq: TRVN) has announced its financial results for the second quarter ended June 30, 2024, along with key operational updates.
Navigating Trevena’s Potential: Buy, Sell, or Hold? Read More
PHILADELPHIA, PA — Passage Bio, Inc. (Nasdaq: PASG) released its financial results for the second quarter ended June 30, 2024, along with significant business highlights.
Passage Bio Reports Q2 2024 Financial Results and Business Updates Read More
PHILADELPHIA, PA — Cabaletta Bio, Inc. (Nasdaq: CABA) announced its financial results for the second quarter ended June 30, 2024, along with key business updates.
Cabaletta Bio Reports Q2 2024 Financial Results and Provides Business Update Read More
MALVERN, PA — Ocugen, Inc. (NASDAQ: OCGN) has announced its financial results for the second quarter of 2024 and provided a business update.
Ocugen Reports Q2 2024 Financial Results and Business Update Read More
PHILADELPHIA, PA — Context Therapeutics Inc. (Nasdaq: CNTX) has announced its financial results for the second quarter ended June 30, 2024, along with recent business highlights.
Context Therapeutics Shines Bright: Q2 Successes and Promising Future Read More
MALVERN, PA — Vishay Intertechnology, Inc. (NYSE: VSH) announced its financial results for the fiscal second quarter ended June 29, 2024, posting stable revenue but noting industry challenges and strategic …
Vishay Intertechnology’s Strategic Roadmap: Navigating Industry Challenges & Expansion Plans Read More
KING OF PRUSSIA, PA — Vertex, Inc. (NASDAQ: VERX) announced its financial results for the second quarter ended June 30, 2024, revealing robust performance and strategic acquisitions to bolster growth.
Vertex, Inc. Shines with Strong Financials and Strategic Growth Initiatives Read More
BALA CYNWYD, PA — Larimar Therapeutics, Inc. (Nasdaq: LRMR) announced its second-quarter 2024 financial results and significant progress in its nomlabofusp development program.
Larimar Therapeutics Reports Q2 2024 Financial Results and Milestones Read More
WAYNE, PA — Aclaris Therapeutics, Inc. (NASDAQ: ACRS) announced its financial results for the second quarter of 2024 and provided a corporate update. The company reported net revenue of $2.8 …
Aclaris Therapeutics Reports Q2 2024 Financial Results and Updates Read More